Flu vaccine makers plan to increase production as they brace for unprecedented winter season

flu shot bottles x thumbnail
Credit: Healthline

Even though flu season doesn’t begin until the fall, major flu vaccine manufacturers say they plan to boost production by about 10 percent, to about 189 million doses, up from 170 million doses last year, to ensure enough doses exist for an anticipated surge in people seeking flu shots.

The Centers for Disease Control and Prevention has taken the rare step of buying 7 million doses directly from manufacturers to be distributed to states for adult vaccination, CDC Director Robert Redfield said in an interview. “This is a big move,” he said.

Getting a flu shot does not protect against the coronavirus, but disease experts said reducing episodes of flu could prove pivotal in freeing up space in hospitals and medical offices to deal with covid-19, the disease caused by the coronavirus.

Even as President Trump and other White House officials downplay the pandemic threat this fall, the flu preparations underscore the alarm among public health officials, clinicians, advocacy groups and industry executives about the additional threat from the coronavirus. The unprecedented convergence of two highly contagious respiratory viruses could happen in the winter, with each pathogen causing life-threatening illness and death.

“We want to take flu off the table, in every way possible, make flu a non-factor,” said LJ Tan, chief strategy officer of the Immunization Action Coalition.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
placebo
Viewpoint — Alternative medicine and the placebo effect: Selling a reassuring illusion of health
_20250221_nib_rfk_trump
Viewpoint: 'Crisis of public trust': Autism support community shocked RFK continues to peddle false claims about the danger of vaccines
ChatGPT-Image-May-18-2026-01_45_05-PM-2
Newest hantavirus conspiracy: Online disinformation turns outbreak into latest ivermectin grift
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
ChatGPT-Image-May-18-2026-12_06_18-PM-2
Defying death: The immortality movement goes mainstream
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.